School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.
Front Immunol. 2019 Jun 21;10:1390. doi: 10.3389/fimmu.2019.01390. eCollection 2019.
Cellular stress responses are often engaged at sites of inflammation and can alter macrophage cytokine production. We now report that macrophages in distinct states of differentiation or in different temporal stages of inflammatory response exhibit differential sensitivity to cell stress mediated alterations in M1-like polarized inflammatory cytokine production. Tunicamycin (Tm) treatment of bone marrow derived macrophages (BMDM) cultured with M-CSF cultured bone marrow derived macrophages (M-BMDM) had markedly amplified M1-like responses to LPS, exhibiting higher levels of IL12p40 and IL12p35 mRNAs while BMDM cultured with GM-CSF, which normally express high IL12 subunit production in response to LPS, were relatively unaltered. Anti-inflammatory IL10 mRNA production in LPS-stimulated M-BMDM was greatly reduced by cell stress. These changes in cytokine mRNA levels resulted from altered rates of transcription and mRNA decay. Stress also altered cytokine protein production. Resident liver macrophages isolated from mice treated with Tm showed elevated levels of IL12 subunit mRNA production following LPS stimulation. Furthermore, macrophages infiltrating the liver during the early phase of acetaminophen injury (24 h) had little stress-mediated change in cytokine mRNA production while cells isolated in the later phase (48-72 h) exhibited higher sensitivity for stress elevated cytokine production. Hence cultured macrophages developed using different growth/differentiation factors and macrophages from different temporal stages of injury show markedly different sensitivity to cell stress for altered inflammatory cytokine production. These findings suggest that cellular stress can be an important modulator of the magnitude and character of myeloid inflammatory activity.
细胞应激反应通常发生在炎症部位,并可改变巨噬细胞细胞因子的产生。我们现在报告称,分化状态不同或处于炎症反应不同时间阶段的巨噬细胞对细胞应激介导的 M1 样极化炎症细胞因子产生的改变表现出不同的敏感性。用衣霉素 (Tm) 处理骨髓来源的巨噬细胞 (BMDM) 与 M-CSF 培养的骨髓来源的巨噬细胞 (M-BMDM) 一起培养,对 LPS 的 M1 样反应明显增强,IL12p40 和 IL12p35 mRNA 的水平更高,而 GM-CSF 培养的 BMDM 通常对 LPS 产生高 IL12 亚基表达,变化相对较小。LPS 刺激的 M-BMDM 中抗炎性的 IL10 mRNA 产生被细胞应激大大减少。这些细胞因子 mRNA 水平的变化源于转录和 mRNA 降解率的改变。应激还改变了细胞因子蛋白的产生。用 Tm 处理的小鼠分离的驻留肝巨噬细胞在 LPS 刺激后表现出更高水平的 IL12 亚基 mRNA 产生。此外,在对乙酰氨基酚损伤的早期阶段(24 小时)浸润肝脏的巨噬细胞在细胞应激后细胞因子 mRNA 产生的变化很小,而在后期阶段(48-72 小时)分离的细胞对应激引起的细胞因子产生增加表现出更高的敏感性。因此,使用不同的生长/分化因子培养的巨噬细胞和不同时间阶段损伤的巨噬细胞对细胞应激引起的炎症细胞因子产生改变表现出明显不同的敏感性。这些发现表明,细胞应激可以是调节髓样炎症活性的幅度和特征的重要调节剂。